Collegium Pharmaceutical (COLL) Change in Acquisitions & Divestments (2023 - 2026)

Collegium Pharmaceutical's Change in Acquisitions & Divestments history runs 4 years deep, the most recent figure standing at $20.0 million for Q1 2026.

• In Q1 2026, Change in Acquisitions & Divestments rose 17.63% year-over-year to $20.0 million; the TTM figure through Mar 2026 stood at $68.2 million (down 22.58% YoY), while the FY2025 annual figure was $65.2 million, down 29.62% from the prior year.
• Change in Acquisitions & Divestments was $20.0 million for Q1 2026 at Collegium Pharmaceutical, up from $19.8 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $29.4 million in Q3 2024 to a low of $13.8 million in Q2 2025.
• Historically, Change in Acquisitions & Divestments has averaged $19.4 million across 4 years, with a median of $18.4 million in 2025.
• Biggest YoY gain for Change in Acquisitions & Divestments was 24.2% in 2025; the steepest drop was 50.49% in 2025.
• A 4-year view of Change in Acquisitions & Divestments shows it stood at $16.0 million in 2023, then fell by 0.15% to $16.0 million in 2024, then increased by 24.2% to $19.8 million in 2025, then grew by 0.83% to $20.0 million in 2026.
• The last three Change in Acquisitions & Divestments figures came in at $20.0 million (Q1 2026), $19.8 million (Q4 2025), and $14.6 million (Q3 2025), per Business Quant data.